HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chang Beom Lee Selected Research

4- (3- amino- 4- (2,4,5- trifluorophenyl)butanoyl)- 3- (tert- butoxymethyl)piperazin- 2- one

4/2024Cardiovascular safety of evogliptin dual and triple therapy in patients with type 2 diabetes: a nationwide cohort study.
11/2023Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension.
1/2021Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study.
12/2017Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise.
1/2017Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chang Beom Lee Research Topics

Disease

11Type 2 Diabetes Mellitus (MODY)
04/2024 - 08/2013
6Obesity
03/2023 - 03/2011
4Abdominal Obesity
03/2023 - 01/2007
4Dyslipidemias (Dyslipidemia)
01/2023 - 01/2020
3Weight Loss (Weight Reduction)
12/2023 - 12/2014
3Prediabetic State (Prediabetes)
12/2023 - 05/2015
3Cardiovascular Diseases (Cardiovascular Disease)
11/2023 - 04/2021
3Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2023 - 07/2010
2Myocardial Infarction
04/2024 - 01/2021
2Heart Failure
04/2024 - 01/2021
2Body Weight (Weight, Body)
02/2024 - 01/2014
2Insulin Resistance
02/2024 - 01/2021
2Diabetes Mellitus
04/2021 - 03/2016
2Inflammation (Inflammations)
09/2013 - 03/2011
1Weight Gain
02/2024
1Non-alcoholic Fatty Liver Disease
02/2024
1Fatty Liver
12/2023
1Drug-Related Side Effects and Adverse Reactions
11/2023
1Stroke (Strokes)
05/2023
1Hypertension (High Blood Pressure)
05/2023
1Angina Pectoris
01/2021
1Hypertriglyceridemia
01/2020
1Chronic Disease (Chronic Diseases)
11/2017
1Hypoparathyroidism
09/2017
1Lymphatic Metastasis
02/2016
1Papillary Thyroid Cancer
02/2016
1Osteoporosis
09/2015
1Vitamin D Deficiency
09/2015
1Postmenopausal Osteoporosis
09/2015
1Glucose Intolerance
05/2015
1Hypoglycemia (Reactive Hypoglycemia)
01/2014
1Asthma (Bronchial Asthma)
03/2011

Drug/Important Bio-Agent (IBA)

6Glucose (Dextrose)FDA LinkGeneric
02/2024 - 01/2007
5Metformin (Glucophage)FDA LinkGeneric
04/2024 - 01/2014
54- (3- amino- 4- (2,4,5- trifluorophenyl)butanoyl)- 3- (tert- butoxymethyl)piperazin- 2- oneIBA
04/2024 - 01/2017
4LipidsIBA
02/2024 - 09/2013
4oxidized low density lipoproteinIBA
05/2023 - 09/2013
3HDL CholesterolIBA
02/2024 - 01/2007
3AdiponectinIBA
02/2024 - 08/2013
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2023 - 05/2015
3LDL CholesterolIBA
05/2023 - 09/2013
3ORALIT (ORS)IBA
01/2023 - 01/2021
2dapagliflozinIBA
02/2024 - 11/2023
2Branched-Chain Amino AcidsIBA
11/2023 - 01/2022
2Indicators and Reagents (Reagents)IBA
01/2022 - 09/2017
23- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA
11/2021 - 08/2019
2Dipeptidyl-Peptidase IV InhibitorsIBA
11/2021 - 08/2019
2glimepiride (Amarel)FDA LinkGeneric
01/2021 - 01/2014
2Triglycerides (Triacylglycerol)IBA
01/2021 - 01/2007
2Insulin (Novolin)FDA Link
01/2021 - 01/2014
2Atorvastatin (Lipitor)FDA Link
01/2020 - 09/2013
1EnzymesIBA
02/2024
1Pioglitazone (Actos)FDA Link
02/2024
1Sodium-Glucose Transporter 2 InhibitorsIBA
02/2024
1SodiumIBA
02/2024
1A 7 (A-7)IBA
12/2023
1CarbohydratesIBA
01/2023
1bisphenol AIBA
04/2021
1Endocrine DisruptorsIBA
04/2021
1CholesterolIBA
01/2021
1Blood Glucose (Blood Sugar)IBA
01/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2021
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2020
1CoffeeFDA Link
11/2017
1Sitagliptin Phosphate (Januvia)FDA Link
01/2017
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
04/2016
125-hydroxyvitamin DIBA
09/2015
1Cholecalciferol (Vitamin D3)FDA Link
09/2015
1Ibandronic Acid (Boniva)FDA Link
09/2015
1hydroxide ionIBA
09/2015
1pitavastatin (itavastatin)FDA Link
05/2015
1Insulin Glargine (Lantus)FDA Link
01/2014
1Therapeutic UsesIBA
01/2014
1Biomarkers (Surrogate Marker)IBA
09/2013
1polyacrylamideIBA
09/2013
1C-Reactive ProteinIBA
09/2013
1AdipokinesIBA
03/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2011
1Hormones (Hormone)IBA
03/2011
1Fatty Acid-Binding ProteinsIBA
07/2010
1OsteocalcinIBA
07/2010

Therapy/Procedure

8Therapeutics
04/2024 - 09/2013
2Bariatric Surgery
03/2023 - 03/2019
2Glycemic Control
08/2019 - 09/2013
2Thyroidectomy
09/2017 - 02/2016
1Drug Therapy (Chemotherapy)
03/2023
1Neck Dissection (Radical Neck Dissection)
02/2016